Latest COVID vaccine adverse events data
Take your time to appreciate the totality of the disaster that is COVID vaccines
The Centers for Disease Control and Prevention (CDC) the other day released new data showing a total of 1,226,314 reports of adverse events following COVID vaccines were submitted between Dec. 14, 2020, and April 8, 2022, to the Vaccine Adverse Event Reporting System (VAERS). VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S.
The data included a total of 26,976 reports of deaths — an increase of 277 over the previous week — and 219,865 serious injuries, including deaths, during the same time period — up 2,564 compared with the previous week.
Foreign reports are reports foreign subsidiaries send to U.S. vaccine manufacturers. Under U.S. Food and Drug Administration (FDA) regulations, if a manufacturer is notified of a foreign case report that describes an event that is both serious and does not appear on the product’s labeling, the manufacturer is required to submit the report to VAERS.
Of the 12,471 U.S. deaths reported as of April 8, 17% occurred within 24 hours of vaccination, 21% occurred within 48 hours of vaccination and 59% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.
In the U.S., 564 million COVID vaccine doses had been administered as of April 8, including 334 million doses of Pfizer, 212 million doses of Moderna and 19 million doses of Johnson & Johnson (J&J).
Historically, VAERS has been shown to report only 1% of actual vaccine adverse events.
U.S. VAERS data from Dec. 14, 2020, to April 8, 2022, for 5- to 11-year-olds show:
18 reports of myocarditis and pericarditis (heart inflammation).
The CDC uses a narrowed case definition of “myocarditis,” which excludes cases of cardiac arrest, ischemic strokes and deaths due to heart problems that occur before one has the chance to go to the emergency department.
39 reports of blood clotting disorders.
U.S. VAERS data from Dec. 14, 2020, to April 8, 2022, for 12- to 17-year-olds show:
166 reports of blood clotting disorders, with all cases attributed to Pfizer.
U.S. VAERS data from Dec. 14, 2020, to April 8, 2022, for all age groups combined, show:
20% of deaths were related to cardiac disorders.
54% of those who died were male, 41% were female and the remaining death reports did not include the gender of the deceased.
The average age of death was 73.
2,373 reports of anaphylaxis where the reaction was life-threatening, required treatment or resulted in death.
1,671 reports of myocardial infarction.